ArticleFrontiers in oncology2025
Development and validation of a preoperative magnetic resonance imaging-based and machine learning model for the noninvasive differentiation of intracranial glioblastoma, primary central nervous system lymphoma and brain metastases: a retrospective analysis.
Article in Frontiers in oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Radiomics-based artificial intelligence models in brain tumors: A systematic review and meta-analysis of diagnostic performance.Neuroradiology · 2026Pooled it
- Interpretable radiomics-based machine learning model for differentiating glioblastoma from primary central nervous system lymphoma using contrast-enhanced T1-weighted imaging.Scientific reports · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Accurate preoperative identification of intracranial glioblastoma (GB), primary central nervous system lymphoma (PCNSL), and brain metastases (BM) is crucial for determining the appropriate treatment strategy. Purpose: We aimed to develop and validate the utility of preoperative magnetic resonance imaging-based radiomics and machine learning models for the noninvasive identification them. STUDY TYPE: Retrospective. POPULATION: We included 202 patients, including 71 GB, 59 PCNSL, and 72 BM, randomly divided into a training cohort (n =141) and a validation cohort (n = 61).FIELD STRENGTH/SEQUENCE: Axial T2-weighted fast spin-echo sequence (T2WI) and contrast-enhanced T1-weighted spin-echo sequence (CE-T1WI) using 1.5-T and 3.0-T scanners. ASSESSMENT: We extracted radiomics features from the T2 sequence and CE-T1 sequence separately. Then, we applied the F-test and recursive feature elimination (RFE) to reduce the dimensionality for both individual sequences and the combined sequence CE-T1 combined with T2.The support vector machine (SVM), k-nearest neighbor (KNN), and naive Bayes classifier (NBC) were used in model development. STATISTICAL TESTS: Chi-square test, one-way analysis of variance, and Kruskal-Wallis test were performed. The P values <0.05 were considered statistically significant. Performance was evaluated using AUC, sensitivity, specificity, and accuracy metrics. Result: The SVM model exhibited superior diagnostic performance with macro-average AUC values of 0.91 for CE-T1 alone, 0.86 for T2 alone, and 0.93 for combined CE-T1 and T2 sequences. And the combined sequence model demonstrated the best overall accuracy, sensitivity, and F1 score, with an accuracy of 0.77, outperforming both KNN and NBC models. Conclusion: The SVM-based MRI radiomics model effectively distinguishes between GB, PCNSL, and BM. Combining CE-T1 and T2 sequences significantly enhances classification performance, providing a robust, noninvasive diagnostic tool that could assist in treatment planning and improve patient outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.